» Articles » PMID: 12022240

Prevalence of Hyperhomocysteinemia in an Elderly Population

Overview
Journal Am J Hypertens
Date 2002 May 23
PMID 12022240
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently, total hyperhomocysteinemia (tHHcy) is a well-known condition linked to a higher risk of vascular disease. Prevalence of HHcy increases in elderly persons as the risk associated with it persists. Because factors can be potentially reduced in the elderly, it is important to carry out epidemiologic studies of HHcy.

Procedure: Previously we described the prevalence of hypertension control in an elder population; now, in an observational cross-sectional simple blind study, total homocysteine (tHcy) concentration was determined in 196 of 400 patients from the original cohort.

Results: Mean Hcy concentration was 13.2 ,amol/L (95% confidence interval 12.4-14.0; range, 5.0 to 48.9); 15.0 ,imol/L for men and 12.3 pAmol/L for women. Mean serum folic acid levels were 4.9 + 3.1 ng/mL (range, 2.0 to 20.0 ng/mL), and vitamin B12 levels were 384.8 314.1 pg/mL (range, 48.0 to 1500.0 pg/mL). Taking into account the reference values established by the Third National Health and Nutrition Examination Survey III study, HHcy was detected in 69.8% of all the subjects evaluated. The study showed that 76.2% of the men and 66.4% of the women had high Hcy levels.

Conclusions: The very high prevalence of tHHcy in the elderly population, and the consequent risks associated with it suggest that although there are no trials that effectively prove the benefit of tHcy decrease, nutritional intervention is still justified.

Citing Articles

The effect of cumulative exposure with unhealthy lifestyles on the H-type hypertension among Chinese adults: a community-based, propensity-score-matched, and case-control study.

Li L, Wang J, Li J, Li M, Long T, Zhengliu Y Front Nutr. 2024; 11:1470788.

PMID: 39360276 PMC: 11445168. DOI: 10.3389/fnut.2024.1470788.


Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review.

Puga A, Ruperto M, Samaniego-Vaesken M, Montero-Bravo A, Partearroyo T, Varela-Moreiras G Nutrients. 2021; 13(9).

PMID: 34578844 PMC: 8470370. DOI: 10.3390/nu13092966.


Hyperhomocysteinemia and its relations to conventional risk factors for cardiovascular diseases in adult Nigerians: the REMAH study.

Chori B, Danladi B, Inyang B, Okoh M, Nwegbu M, Alli A BMC Cardiovasc Disord. 2021; 21(1):102.

PMID: 33602121 PMC: 7890880. DOI: 10.1186/s12872-021-01913-x.


Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke.

Poddar R Exp Neurol. 2020; 336:113541.

PMID: 33278453 PMC: 7856041. DOI: 10.1016/j.expneurol.2020.113541.


Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer's disease.

Braun D, Dimayuga E, Morganti J, Van Eldik L J Neuroinflammation. 2020; 17(1):274.

PMID: 32943069 PMC: 7499995. DOI: 10.1186/s12974-020-01938-7.